Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled study of nebivolol versus bisoprolol in Chinese adults with mild to moderate essential hypertension
CTR20191808Phase 3Active
- Sponsor
- Menarini Group
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol, bisoprolol in essential hypertension, sponsored by Menarini Group. Started Jan 2021; status: active.
02
Drugs
nebivololbisoprolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20191808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191808.